Letters Cardiovascular risk scores and prescribing in diabetes BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7394.882 (Published 19 April 2003) Cite this as: BMJ 2003;326:882 Article Related content Metrics Responses Peer review Related articles Paper Controlled trial of effect of documented cardiovascular risk scores on prescribing Published: 01 February 2003; BMJ 326 doi:10.1136/bmj.326.7383.251 See more FDA approves first over-the-counter blood glucose monitor for diabetes BMJ March 11, 2024, 384 q611; DOI: https://doi.org/10.1136/bmj.q611 US food manufacturer can say that eating yogurt reduces risk of type 2 diabetes, says FDA BMJ March 06, 2024, 384 q569; DOI: https://doi.org/10.1136/bmj.q569 Scarlett McNally: Preventing obesity is different from curing it—and even more urgent BMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134 Artificial pancreases for type 1 diabetes: Better access is “watershed moment”—but delivery is key BMJ January 23, 2024, 384 q102; DOI: https://doi.org/10.1136/bmj.q102 GLP-1 agonist shortage will last until end of 2024, government warns BMJ January 05, 2024, 384 q28; DOI: https://doi.org/10.1136/bmj.q28